Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: john.d who wrote (6753)	2/12/2001 11:49:50 PM
From: veliny	Read Replies (1) of 14101

WF10 and Drugs for the Poor Interesting article in the Financial Times today. Oxfam backed by several large institutional investors is taking GlaxoSmithKline to task over the issue of putting drugs profits ahead of delivering life saving drugs to poor countries in desperate needs of vital medicines. Oxfam wants GSK to withdraw their drug patents registered in poorer countries so that cheaper alternatives can be delivered to these states. I believe I read a post earlier (by Wilyovet?) that our expectations for financial success with medicines like WF10 may be limited by societies obligation to make them available to a broad portion of the world's population at no or little cost. I am sure we will not hear the last of this issue in the coming months and years.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next